In this article, we deep dive into the 5 stocks boasting double-digit gains on Tuesday. For a deeper discussion and an extended list, please see 10 Stocks Turning Heads With Double-Digit Gains.

5. Cytokinetics Inc. (NASDAQ:CYTK)

Cytokinetics rallied for a second day on Tuesday, to hit a new 52-week high, as investors gobbled up shares following a stellar first quarter revenue performance, supported by the strong sales for its newly-launched heart disease treatment, myqorzo.

At intra-day trade, the stock climbed to a record high of $80.20 before paring gains to finish the session just up by 16.71 percent at $77.09 apiece.

In an updated report, Cytokinetics Inc. (NASDAQ:CYTK) said that it raked in $19.3 million in revenues for the first quarter of the year, marking a 1,121 percent expansion from only $1.58 million in the same period last year.

Growth was primarily driven by net product, license, and milestone revenues, which amounted to $16.7 million, versus none in the same period a year earlier.

Meanwhile, Cytokinetics Inc. (NASDAQ:CYTK) remained at a net loss of $206 million, or 28 percent higher than the $161 million in the same comparable quarter.

“The US launch of myqorzo commenced strongly in late January and continues to accelerate. We promptly activated a solid prescriber base of early adopters and are encouraged by initial commercial metrics that are exceeding our expectations,” Cytokinetics Inc. (NASDAQ:CYTK) President and CEO Robert Blum said.

The company began the commercial launch of Myqorzo in January this year, with more than 275 unique healthcare providers already prescribing the medicine.

It also secured the approval of the European Commission for Myrqozo to treat symptomatic (NYHA class II-III) oHCM in adult patients, with the first launch targeted in Germany within the second quarter of the year.

4. Fastly Inc. (NASDAQ:FSLY)

Fastly grew its share prices by 17.72 percent on Tuesday to close at $32.36 apiece, as investors loaded portfolios ahead of the results of its first quarter earnings performance, which came shortly after market close.

Earlier, the company announced targets of growing its revenues by 16 to 20.4 percent to a range of $168 million to $174 million in the first quarter of the year, versus the $144.5 million in the same period last year.

It also expects to swing to a non-GAAP net income per share of $0.07 to $0.10 from a non-GAAP net loss per share of $0.05 posted in the same comparable period.

Non-GAAP operating income is pegged at $14 million to $18 million, or an implied reversal of the $5.8 million non-GAAP operating loss year-on-year.

In other news, Fastly Inc. (NASDAQ:FSLY) earlier this month teamed up with Spain-based professional football association, Laliga, in combating piracy and illegal streaming of its live sports.

Under the agreement, Fastly Inc. (NASDAQ:FSLY) and Laliga will collaborate on a joint anti-piracy innovation project leveraging AI for a targeted, intelligent detection system that is able to identify illegal streams in real time.

Fastly and Laliga said that they are actively collaborating with other technology companies, publishers, and regulators to develop software solutions and best practices that quickly detect and disable unauthorized streaming while leaving all other traffic untouched.

3. Cipher Digital Inc. (NASDAQ:CIFR)

Cipher Digital grew its share prices by 23.53 percent on Tuesday to finish at $22.10 apiece, as investors took heart from the massive progress of its two data center developments, saying that 2026 “is the year of execution.”

In an updated report, Cipher Digital Inc. (NASDAQ:CIFR) announced developments at its Barber Lake and Black Pearl campuses, saying that it built momentum from the bagging of new long-term deals from hyperscalers.

Last month, Cipher Digital Inc. (NASDAQ:CIFR) successfully topped out the Barber Lake data center, with mechanical, electrical, and networking work now underway.

Meanwhile, retrofitting of the existing data center structure for the first phase of Black Pearl remains on track, with layout and site work for phase 2 targeted in April.

“We also secured our first corporate revolving credit facility, strengthening our liquidity position by providing up to $200 million of committed borrowing capacity from leading global financial institutions. Looking forward, we will continue to build on this momentum and establish ourselves as the leading HPC development platform,” Cipher Digital Inc. (NASDAQ:CIFR) CEO Tyler Page said.

The announcement overshadowed a dismal earnings performance in the first quarter of the year, with net loss attributable to shareholders widening by 192 percent to $114 million from only $38.97 million in the same period last year.

Revenues came solely from Bitcoin mining, dropping 28.8 percent to $34.8 million from $48.9 million in the same comparable period.

2. Viridian Therapeutics Inc. (NASDAQ:VRDN)

Viridian Therapeutics extended gains for a second day on Tuesday, soaring 33.36 percent to close at $18.75 apiece, as investor sentiment was bolstered by the looming commercialization of its eye disease treatment.

In an updated report, Viridian Therapeutics Inc. (NASDAQ:VRDN) announced readiness for the launch of veligrotug, its treatment for active and chronic thyroid eye disease (TED).

It said that it already hired a field team, including sales, to support the commercialization and supply chain infrastructure, and engaged with physicians, payers, and key opinion leaders for the treatment.

“We believe we are well-prepared and well-positioned to deliver a successful launch. With the positive topline data from REVEAL-1 and REVEAL-2, in active and chronic TED, respectively, we believe that subcutaneous elegrobart has the potential to be the simplest and most convenient treatment for TED,” Viridian Therapeutics Inc. (NASDAQ:VRDN) President and CEO Steve Mahoney said.

The company also submitted a marketing authorization application with the European Medicines Agency last January, which was accepted for review in February 2026.

Veligrotug aside, Viridian Therapeutics Inc. (NASDAQ:VRDN) widened its net loss attributable to common shareholders by 30 percent in the first quarter of the year to $92 million from $70.69 million in the same period last year.

Total revenues soared by 96 percent to $141 million from $72 million year-on-year.

1. DigitalOcean Holdings Inc. (NYSE:DOCN)

DigitalOcean extended its winning streak to a third straight session on Tuesday, to hit a new all-time high, as investors took heart from its stellar revenue performance and a highly optimistic outlook for the second quarter of the year.

At intra-day trade, the stock climbed to its highest price of $153.47 before paring gains to finish the session just up by 40.40 percent at $152.77 apiece.

In a statement, DigitalOcean Holdings Inc. (NYSE:DOCN) said that it raked in $257.9 million in revenues for the first three months of the year, marking a 22.4 percent jump from the $210.7 million in the same period a year earlier.

However, net income attributable to shareholders fell by 58.7 percent to $15.77 million from $38.2 million.

Looking ahead, DigitalOcean Holdings Inc. (NYSE:DOCN) is targeting its revenues for the second quarter of the year to grow by 24 to 25 percent to a range of $272 million to $274 million. For the full-year period, revenues are expected to soar by 25 to 27 percent to a range of $1.13 billion to $1.145 billion.

“The Inference and agentic era needs its own cloud. DigitalOcean built it, and our record Q1 results demonstrate the strength of our platform,” DigitalOcean Holdings Inc. (NYSE:DOCN) CEO Paddy Srinivasan said, noting that it exceeded its revenue and profitability guidance.

“We continue to invest in what we believe is a generational market opportunity, adding approximately 60 MW of incremental committed data center capacity that will come online throughout 2027 to support growing customer demand,” he noted.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.